Crucell (CRXLY) Stock Price, News & Analysis

Company Overview

Crucell N.V. (OTCMKTS:CRXLY) is a biopharmaceutical company specializing in the development, manufacture and commercialization of preventive vaccines and antibody-based therapeutics. The company’s core expertise lies in its proprietary PER.C6 cell platform for scalable vaccine production and its AdVac adenoviral vector technology for innovative vaccine candidates. These platforms underpin a diverse pipeline aimed at combating infectious diseases in both human and veterinary markets.

Founded in 1993 and headquartered in the Netherlands, Crucell gained recognition for its work on polio and rabies vaccines before expanding into influenza, Ebola and other high-priority pathogens. In addition to its own product portfolio, the company provides contract development and manufacturing services to global biopharma partners, leveraging its cell line engineering, process optimization and regulatory experience to accelerate time-to-market for novel biologics.

Crucell maintains research, development and production facilities across Europe, North America and Asia, with commercial reach into developed and emerging markets worldwide. Strategic collaborations with governmental health agencies, academic institutions and pharmaceutical companies support the distribution of its vaccines and ensure access in regions where immunization programs play a critical role in public health.

Under the leadership of seasoned executives—most notably former CEO Jan ter Meulen—the company fortified its R&D capabilities and built a well-rounded product pipeline. This expertise and scientific heritage paved the way for a strategic acquisition by a leading healthcare group, ensuring that Crucell’s innovative vaccine technologies continue to influence global immunization efforts.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CRXLY Stock Analysis - Frequently Asked Questions

How do I buy shares of Crucell?

Shares of CRXLY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:CRXLY
• Previous Symbol: NASDAQ:CRXL
• CIK: N/A
• Web: N/A
• Phone: +31-71-5199100
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A